Charles Schwab’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Buy |
|
|||||
|
2025
Q1 | $1.1M | Sell |
|
|||||
|
2024
Q4 | $2.47M | Sell |
|
|||||
|
2024
Q3 | $2.03M | Buy |
|
|||||
|
2024
Q2 | $1.09M | Buy |
|
|||||
|
2024
Q1 | $231K | Hold |
|
|||||
|
2023
Q4 | $165K | Hold |
|
|||||
|
2023
Q3 | $109K | Hold |
|
|||||
|
2023
Q2 | $80.8K | Sell |
|
|||||
|
2023
Q1 | $403K | Buy |
|
|||||
|
2022
Q4 | $836K | Buy |
|
|||||
|
2022
Q3 | $751K | Buy |
|
|||||
|
2022
Q2 | $422K | Buy |
|
|||||
|
2022
Q1 | $1.71M | Buy |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $1.9M | Buy |
|
|||||
|
2021
Q2 | $569K | Buy |
|
|||||
|
2021
Q1 | $514K | Buy |
|
|||||
|
2020
Q4 | $434K | Buy |
|
|||||
|
2020
Q3 | $260K | Buy |
|
|||||
|
2020
Q2 | $546K | Buy |
|
|||||
|
2020
Q1 | $320K | Buy |
|